Perceptive Advisors LLC Puma Biotechnology, Inc. Call Options Transaction History

Perceptive Advisors LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2018 Aug 14, 2018	SELL	$48.3 - $68.25 $4.83 Million - $6.83 Million	-100,000 Reduced 50.0%	100,000 $187,000
Q1 2018 May 15, 2018	BUY	$59.7 - $99.25 $5.97 Million - $9.93 Million	100,000 Added 100.0%	200,000 $1.61 Million
Q4 2017 Feb 14, 2018	BUY	$93.85 - $132.45 $9.39 Million - $13.2 Million	100,000	100,000 $55,000

102

29.1M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $132M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.